Zhang, Ling
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Ling
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

Recruiting
3
368
Europe, US, RoW
SHR0302, Placebo
Reistone Biopharma Company Limited, Reistone Biopharma Company Limited
Ulcerative Colitis
10/24
03/25
NCT05267288: Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer

Recruiting
2
30
RoW
afatinib, bevacizumab
Qingdao Central Hospital
PFS
12/24
06/25
NCT06081920: A Study of IBI363 in Subjects With Advanced Melanoma

Recruiting
2
120
RoW
IBI363
Innovent Biologics (Suzhou) Co. Ltd.
Melanoma
06/25
07/26
NCT04714918: Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Recruiting
N/A
10254
RoW
Limeng Chen
Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder
12/24
12/24
NCT05730803: Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation

Not yet recruiting
N/A
1200
RoW
dietary intervention
Tianjin Medical University
Nutritional Requirements
12/27
12/27

Download Options